Tissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of MetalloproteinasesTissue Inhibitor of Metalloproteinase-2BenzenesulfonatesPhenylurea CompoundsNiacinamideTissue Inhibitor of Metalloproteinase-3Phosphatidylethanolamine Binding ProteinPyridinesMatrix Metalloproteinase 2Matrix Metalloproteinase 9MetalloendopeptidasesMatrix MetalloproteinasesGelatinasesMatrix Metalloproteinase 3Protein Kinase InhibitorsMatrix Metalloproteinase 1Matrix Metalloproteinase InhibitorsCollagenasesProtease InhibitorsProton-Translocating ATPasesMatrix Metalloproteinases, Membrane-AssociatedAntineoplastic AgentsProteinsHand-Foot SyndromeMitochondria, HeartSubmitochondrial Particlesraf KinasesAurovertinsAngioedemaMolecular Sequence DataAmino Acid SequenceCarcinoma, HepatocellularEnzyme InhibitorsRNA, MessengerLiver NeoplasmsCattleCarcinoma, Renal CellMatrix Metalloproteinase 8Complement C1 Inactivator ProteinsCell Line, TumorKidney NeoplasmsGlycoproteinsMetalloproteasesAndrogen-Binding ProteinCells, CulturedBlotting, WesternEnzyme PrecursorsProtein BindingEnzyme ActivationMicrobial CollagenaseKineticsExtracellular MatrixMatrix Metalloproteinase 7ApoptosisMatrix Metalloproteinases, SecretedSignal TransductionPhosphorylationAlpha-GlobulinsMatrix Metalloproteinase 14Electrophoresis, Polyacrylamide GelImmunohistochemistryReverse Transcriptase Polymerase Chain ReactionCell ProliferationMatrix Metalloproteinase 13Recombinant ProteinsCarrier ProteinsCollagenFoot DermatosesFibroblastsMatrix Metalloproteinase 10Placental HormonesI-kappa B ProteinsBase SequencePyrrolesProto-Oncogene Proteins c-rafMyeloid Cell Leukemia Sequence 1 ProteinRibonuclease, PancreaticPhenylmercuric AcetateUracil-DNA GlycosidaseDose-Response Relationship, DrugEndo-1,4-beta XylanasesMolecular WeightAdenosine TriphosphateMatrix Metalloproteinase 15Up-RegulationNF-kappa BAntineoplastic Combined Chemotherapy ProtocolsGene ExpressionBinding SitesPlant ProteinsGene Expression RegulationDrug SynergismADAM ProteinsMitochondrial Proton-Translocating ATPasesTreatment OutcomeBlotting, NorthernAntineoplastic ProtocolsTime FactorsPeptide Fragments